tiprankstipranks
CStone Pharmaceuticals (HK:2616)
HKEX:2616
Hong Kong Market

CStone Pharmaceuticals (2616) Ownership - Who Owns CStone Pharmaceuticals?

0 Followers

CStone Pharmaceuticals (2616) Ownership Overview

0.00%1.13%0.61%98.26%
0.00%
Insiders
0.61% Other Institutional Investors
98.26% Public Companies and
Individual Investors
The ownership structure of CStone Pharmaceuticals (HK:2616) stock is a mix of institutional, retail and individual investors. Approximately 1.74% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 98.26% is owned by Public Companies and Individual Investors.
The ownership structure of CStone Pharmaceuticals (HK:2616) stock is a mix of institutional, retail and individual investors. Approximately 1.74% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 98.26% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,266,500Institution0.64%1,223,442
7,704,500Institution0.60%1,140,266
5,858,876Institution0.46%867,114
262,500Institution0.02%38,850
173,500Institution0.01%25,678
137,500Institution0.01%20,350

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
8,266,500Institution0.64%1,223,442
5,858,876Institution0.46%867,114
262,500Institution0.02%38,850
173,500Institution0.01%25,678

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,242,500Institution0.49%931,240
1,459,000Institution0.11%217,650
99,500Institution<0.01%14,516
38,000Institution<0.01%5,544
1,500Institution<0.01%222
1,500Institution<0.01%222

FAQ

Who Owns CStone Pharmaceuticals (HK:2616)?
According to the latest TipRanks data, approximately 0.61% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 98.26% is held by retail investors.
    What percentage of CStone Pharmaceuticals (HK:2616) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.61% of CStone Pharmaceuticals (HK:2616) stock is held by institutional investors.
      What percentage of CStone Pharmaceuticals (HK:2616) stock is held by retail investors?
      According to the latest TipRanks data, approximately 98.26% of CStone Pharmaceuticals (HK:2616) stock is held by retail investors.
        Who owns the most shares of CStone Pharmaceuticals (HK:2616)?
        VANGUARD INTERNATIONAL EQUITY INDEX FUNDS owns the most shares of CStone Pharmaceuticals (HK:2616).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis